# Migränhjälpen Norden

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/migranhjalpen-norden

- Industry: Software
- Headquarters: Sweden
- Website: www.migranhjalpen.se
- Total disclosed funding: $0.6M
- Latest round: Seed (Mar 5, 2020)
- Investors on record: 2

## About

Migränhjälpen Norden AB provides digital diagnostic and treatment services for individuals suffering from migraines and severe headaches in Sweden, utilizing technology to connect patients with healthcare professionals efficiently.Founded in 2019, Migränhjälpen Norden AB is based in Sweden and focuses on offering digital healthcare services for headache management. The company has successfully raised SEK 10 million in funding as of May 11, 2021, targeting improved patient access to specialized care. The leadership team includes CEO Charlotta Tönsgård, while the founders are Alexander K, Alexander Knezevic, and Johan Nyberg.Migränhjälpen specializes in digital diagnostic and treatment services for individuals suffering from severe headaches and migraines. The core offerings include assessments, diagnostics, connections with neurologists, and preventive treatments via a digital platform, ensuring accessible care throughout Sweden. The service model allows for video consultations, facilitating timely interventions without physical examinations, catering to patients with chronic and episodic migraines as well as tension-type headaches.In the most recent financial year of 2023, Migränhjälpen reported revenues of SEK 1,586,321.50, alongside an EBITDA of SEK -1,253,353, reflecting the financial dynamics of their operational model centered around direct-to-consumer consultations and ongoing care.Migränhjälpen Norden AB plans to utilize the SEK 10 million raised in May 2021 to enhance its digital platform and expand its service offerings. The company is exploring opportunities to launch new products aimed at improving patient experience and is targeting geographic expansion into additional regions within Sweden. These strategic initiatives are part of their overall growth strategy to increase access to migraine treatment and management solutions.

## Funding rounds

- Seed, Mar 5, 2020, $0.6M — ALMI Invest, Add Health Media

## Investors

- ALMI Invest — Seed
- Add Health Media (https://capitalatlas.ai/funds/add-health-media) — Seed